GS0051: pharmaceuticals, namely, proteins, lipids, nucleotide molecules, cell lines and cell line products, namely, cell line pharmaceutical proteins and preparations, and vaccines, all for the prevention and treatment of cancer, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases
Case File Event Statements
5/19/2001 - 23 years ago
17 - ABANDONMENT - NO USE STATEMENT FILEDType:ABN6
7/24/2000 - 24 years ago
16 - EXTENSION 3 GRANTEDType:EX3G
5/26/2000 - 24 years ago
15 - EXTENSION 3 FILEDType:EXT3
2/7/2000 - 25 years ago
14 - EXTENSION 2 GRANTEDType:EX2G
12/10/1999 - 25 years ago
13 - EXTENSION 2 FILEDType:EXT2
6/23/1999 - 25 years ago
12 - EXTENSION 1 GRANTEDType:EX1G
6/23/1999 - 25 years ago
11 - EXTENSION 1 FILEDType:EXT1
1/5/1999 - 26 years ago
10 - NOA MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
10/13/1998 - 26 years ago
9 - PUBLISHED FOR OPPOSITIONType:PUBO
9/11/1998 - 26 years ago
8 - NOTICE OF PUBLICATIONType:NPUB
7/27/1998 - 26 years ago
7 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
7/27/1998 - 26 years ago
6 - ASSIGNED TO EXAMINERType:DOCK
7/6/1998 - 26 years ago
5 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA